» Articles » PMID: 38933104

Advancements in the Study of Acute Lung Injury Resulting from Intestinal Ischemia/reperfusion

Overview
Specialty General Medicine
Date 2024 Jun 27
PMID 38933104
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal ischemia/reperfusion is a prevalent pathological process that can result in intestinal dysfunction, bacterial translocation, energy metabolism disturbances, and subsequent harm to distal tissues and organs via the circulatory system. Acute lung injury frequently arises as a complication of intestinal ischemia/reperfusion, exhibiting early onset and a grim prognosis. Without appropriate preventative measures and efficacious interventions, this condition may progress to acute respiratory distress syndrome and elevate mortality rates. Nonetheless, the precise mechanisms and efficacious treatments remain elusive. This paper synthesizes recent research models and pertinent injury evaluation criteria within the realm of acute lung injury induced by intestinal ischemia/reperfusion. The objective is to investigate the roles of pathophysiological mechanisms like oxidative stress, inflammatory response, apoptosis, ferroptosis, and pyroptosis; and to assess the strengths and limitations of current therapeutic approaches for acute lung injury stemming from intestinal ischemia/reperfusion. The goal is to elucidate potential targets for enhancing recovery rates, identify suitable treatment modalities, and offer insights for translating fundamental research into clinical applications.

References
1.
Bian W, Chen Y, Xu B, Tang J . Pretreatment with Propofol Reduces Pulmonary Injury in a Pig Model of Intestinal Ischemia-Reperfusion via Suppressing the High-Mobility Group Box 1 Protein (HMGB1)/Toll-Like Receptor 4 (TLR4)/Protein Kinase R (PKR) Signaling Pathway. Med Sci Monit. 2021; 27:e930478. PMC: 8142706. DOI: 10.12659/MSM.930478. View

2.
Fantozzi E, Rodrigues-Garbin S, Ricardo-da-Silva F, Oliveira-Filho R, Spina D, Tavares-de-Lima W . Acute lung injury induced by intestinal ischemia and reperfusion is altered in obese female mice. Pulm Pharmacol Ther. 2018; 49:54-59. DOI: 10.1016/j.pupt.2018.01.005. View

3.
Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt R . C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest. 2002; 110(12):1823-30. PMC: 151656. DOI: 10.1172/JCI16577. View

4.
Zhao M, Tang F, Huang X, Ma J, Wang F, Zhang P . Polysaccharide Isolated from Murill Alleviates Intestinal Ischemia/Reperfusion Injury through Regulating Gut Microbiota and Mitigating Inflammation in Mice. J Agric Food Chem. 2024; 72(4):2202-2213. DOI: 10.1021/acs.jafc.3c08482. View

5.
Wada K, Montalto M, Stahl G . Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology. 2001; 120(1):126-33. DOI: 10.1053/gast.2001.20873. View